Shareholder Urges Taro To Side With Activist's Board Picks

Law360, New York (August 7, 2013, 1:26 PM EDT) -- The Taro Pharmaceuticals Industries Ltd. shareholder that earlier this year helped thwart a takeover urged the company on Wednesday to endorse board nominees proposed by activist investor BlueMountain Capital Management LLC, stoking a battle for control in the leadup to Taro's annual meeting.

New York-based IsZo Capital Management LP, one of Taro's largest minority shareholders with 2 percent of its stock, sent a letter to the Israeli company's board calling for a shakeup that it contends will restore investor faith in Taro and unlock new returns....
To view the full article, register now.